Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Oncology

Journal Scan / Research · June 05, 2024

Long-Course vs Short-Course Androgen Deprivation Therapy Plus Postoperative Radiotherapy for Prostate Cancer

The Lancet

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial
Lancet 2024 Jun 01;10442(403)2416-2425, CC Parker, H Kynaston, AD Cook, NW Clarke, CN Catton, WR Cross, PM Petersen, RA Persad, CA Pugh, F Saad, J Logue, H Payne, LC Bower, C Brawley, M Rauchenberger, M Barkati, DM Bottomley, K Brasso, HT Chung, PWM Chung, R Conroy, A Falconer, V Ford, CL Goh, CM Heath, ND James, C Kim-Sing, R Kodavatiganti, SC Malone, SL Morris, A Nabid, AD Ong, R Raman, S Rodda, P Wells, J Worlding, WR Parulekar, MKB Parmar, MR Sydes

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading